Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative Study
Lists
Only you see this
Abstract
In our study cohort, AS is not inferior to PI in patients with SRM suspicious for renal cell carcinoma. The difference in OS between AS and PI is most likely attributable to the increased risk of death from competing causes among AS patients. A priori definitions of progression, including growth rate, should be reconsidered.
BibTeX
@article{alkhatib2025active,
author = {Khalid Y. Alkhatib and Joseph Cheaib and Maximilian Pallauf and Ridwan Alam and Hiten D. Patel and Tina Wlajnitz and Nirmish Singla and Peter Chang and Andrew A. Wagner and Christian P. Pavlovich and James M. McKiernan and Thomas J. Guzzo and Mohamad E. Allaf and Phillip M. Pierorazio},
title = {{Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative Study}},
journal = {The Journal of Urology},
year = {2025},
doi = {10.1097/ju.0000000000004583},
}Loading related content...